The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
May. 05, 2026
Filed:
Jan. 27, 2025
Applicant:
Acerta Pharma B.v., Oss, NL;
Inventors:
Stephen Atkinson, Saffron Walden, GB;
Gerjan De Bruin, Oss, NL;
Flavia Izzo, Oss, NL;
Chimed Jansen, Oss, NL;
Olaf Kinzel, Oss, NL;
Martin Packer, Macclesfield, GB;
Saskia Verkaik, Oss, NL;
Robin Voets, Oss, NL;
Assignee:
ACERTA PHARMA B.V., Oss, NL;
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 31/437 (2006.01); A61K 31/439 (2006.01); A61K 31/4545 (2006.01); A61K 31/506 (2006.01); A61K 31/5377 (2006.01); A61K 31/55 (2006.01); C07D 471/04 (2006.01);
U.S. Cl.
CPC ...
A61K 31/437 (2013.01); A61K 31/439 (2013.01); A61K 31/4545 (2013.01); A61K 31/506 (2013.01); A61K 31/5377 (2013.01); A61K 31/55 (2013.01); C07D 471/04 (2013.01);
Abstract
Compounds having the structure of Formula (I): and pharmaceutically acceptable salts thereof, wherein R, R, R, R, and A are as defined in the specification; pharmaceutical compositions comprising such compounds and salts; use of such compounds and salts to treat or prevent Menin-mediated conditions; kits comprising such compounds and salts; and methods for manufacturing such compounds and salts.